Navigation Links
Basil Zimmo Joins Finesse Solutions as Vice-President of Software
Date:5/6/2008

SANTA CLARA, Calif., May 6 /PRNewswire/ -- Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the appointment of Basil Zimmo as its Vice-President of Software. Basil brings over 19 years of international program and senior management experience, with a focus on implementing high efficiency engineering, resource optimization, and global performance metrics. Basil was most recently a Senior Program Manager for handheld products at Research in Motion (RIM). Prior to joining RIM, Basil held senior management roles at Picarro Canada, Inc. and telecommunications companies such as Nortel Networks and JDS Uniphase, and has held positions at semiconductor chip companies such as AMD, Mitel Semiconductor, Phillips Semiconductor, GEC Plessey and Hughes Aircraft Company.

At Finesse Solutions, Mr. Zimmo will lead the new, Santa Clara-based software team in developing the TruBio bioreactor control platform. Mr. Zimmo said, "I am delighted to join Finesse, and work closely with both sensor and hardware teams to develop the next generation TruBio software. Finesse has a unique opportunity to innovate and address the evolving needs of bio-processing applications."

According to Finesse Solutions CEO Dr. Barbara Paldus, "We are delighted to embark on developing future versions of TruBio software based on state-of-the art programming platforms, that will future-proof our offering and add new capabilities for end users. We look forward to offering end users significantly improved code and novel, advanced features in the near future."

About Finesse Solutions, LLC

California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries. For more information, please visit us at http://www.finesse.com.


'/>"/>
SOURCE Finesse Solutions, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Drugs from Johnson & Johnson/Basilea and Forest Are the Most Promising Antibiotics in the Community-Acquired Pneumonia Pipeline
2. Trisha Dowling Joins Biomatrica as Vice President, Sales and Marketing
3. Michael D. Taylor, Ph.D., Joins Cequent Pharmaceuticals Board of Directors
4. Harvey Morgan Joins CryoLife Board of Directors
5. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
6. Dr. Arie S. Belldegrun, MD, FACS Joins Two River Group Holdings as Chairman and Partner
7. Robert W. Lee, Ph.D. Joins Particle Sciences as Vice President of Pharmaceutical Development
8. Dr. Elizabeth Brown Joins Argenta TEC
9. David S. Tierney, M.D., Joins Thomas, McNerney & Partners as Entrepreneur-In-Residence
10. Matthew J. Pfeffer Joins MannKind as Corporate Vice President and Chief Financial Officer
11. The Scripps Translational Science Institute Joins The MetaMiner Cardiac Consortium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016 Soligenix, Inc. (OTCQB: ... focused on developing and commercializing products to treat rare ... today that it will be hosting an Investor Webcast ... on the origins of innate defense regulators (IDRs) as ... of oral mucositis and the recently announced and published ...
(Date:12/8/2016)... Dec. 8, 2016 Eutilex Co. Ltd. today ... (US $18.9M) Series A financing. This financing round included ... Venture and SNU Bio Angel. This new funding brings ... KRW (US $27.7M) since its founding in 2015. ... the development and commercialization of its immuno-oncology programs, expand ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... its phase I/II dose escalation and expansion clinical trial for its lead drug ... Austria. The purpose of the trial was to determine the safety, antitumor activity, ...
(Date:12/7/2016)... 2016 Neogen Corporation (NASDAQ: NEOG ... Kephart as its chief science officer — a ... responsibilities at Neogen effective Jan. 1. Kephart ... agribusiness unit of Thermo Fisher Scientific, as well as ... His extensive industry experience also includes the management of ...
Breaking Biology Technology:
(Date:12/7/2016)... 7, 2016   Avanade is helping Williams ... teams in history, exploit biometric data in order to ... maintain the competitive edge against their rivals after their ... Avanade has worked with Williams during the 2016 ... data (heart rate, breathing rate, temperature and peak acceleration) ...
(Date:12/5/2016)... Dec. 5, 2016  The Office of Justice ... "Can CT Scans Enhance or Replace Medico Legal ... of supporting or replacing forensic autopsies with postmortem ... In response to recommendations made by ... using CT scans as a potential component of ...
(Date:11/29/2016)... BioDirection, a privately held medical device company developing novel ... concussion and other traumatic brain injury (TBI), announced today ... the U.S. Food and Drug Administration (FDA) to review ... meeting company representatives reviewed plans for clinical development of ... a planned pilot trial. "We are ...
Breaking Biology News(10 mins):